Dr. Clare Craig Explains Why FDA Should Not Have Granted Approval for Roll-Out in the 6 Mo To 4 Yr O

First published at 18:43 UTC on June 21st, 2022.
subscribers

This trial should have been deemed null and void. The regulators are failing to do their job.

The FDA voted unanimously to approve the drug for this age group. Given the problems outlined, this is unbelievable.

Please Subscribe and Share, it'…

MORE
CategoryNews & Politics
SensitivityNormal - Content that is suitable for ages 16 and over
DISCUSS THIS VIDEO